LivaNova Initiates BELIEVE Aortic Heart Valve Study in the U.S. and Canada

by in

LivaNova today announced that the first patient has been enrolled in the Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant Study (“BELIEVE”).